The Evolution and Variety of RFamide-Type Neuropeptides: Insights from Deuterostomian Invertebrates by Maurice R. Elphick & Olivier Mirabeau
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
REVIEW ARTICLE
published: 19 June 2014
doi: 10.3389/fendo.2014.00093
The evolution and variety of RFamide-type neuropeptides:
insights from deuterostomian invertebrates
Maurice R. Elphick 1* and Olivier Mirabeau2
1 School of Biological and Chemical Sciences, Queen Mary University of London, London, UK
2 Institut Curie, Cancer Genetics Unit, Inserm U830, Paris, France
Edited by:
Hubert Vaudry, University of Rouen,
France
Reviewed by:
G. J. Dockray, University of Liverpool,
UK
Robert James Walker, University of
Southampton, UK
*Correspondence:
Maurice R. Elphick, School of
Biological and Chemical Sciences,
Queen Mary University of London,
Mile End Road, London E1 4NS, UK
e-mail: m.r.elphick@qmul.ac.uk
Five families of neuropeptides that have a C-terminal RFamide motif have been identified
in vertebrates: (1) gonadotropin-inhibitory hormone (GnIH), (2) neuropeptide FF (NPFF),
(3) pyroglutamylated RFamide peptide (QRFP), (4) prolactin-releasing peptide (PrRP), and
(5) Kisspeptin. Experimental demonstration of neuropeptide–receptor pairings combined
with comprehensive analysis of genomic and/or transcriptomic sequence data indicate that,
with the exception of the deuterostomian PrRP system, the evolutionary origins of these
neuropeptides can be traced back to the common ancestor of bilaterians. Here, we review
the occurrence of homologs of vertebrate RFamide-type neuropeptides and their recep-
tors in deuterostomian invertebrates – urochordates, cephalochordates, hemichordates,
and echinoderms. Extending analysis of the occurrence of the RFamide motif in other bila-
terian neuropeptide families reveals RFamide-type peptides that have acquired modified
C-terminal characteristics in the vertebrate lineage (e.g., NPY/NPF), neuropeptide fami-
lies where the RFamide motif is unique to protostomian members (e.g., CCK/sulfakinins),
and RFamide-type peptides that have been lost in the vertebrate lineage (e.g., luqins).
Furthermore, the RFamide motif is also a feature of neuropeptide families with a more
restricted phylogenetic distribution (e.g., the prototypical FMRFamide-related neuropep-
tides in protostomes).Thus, the RFamide motif is both an ancient and a convergent feature
of neuropeptides, with conservation, acquisition, or loss of this motif occurring in different
branches of the animal kingdom.
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INTRODUCTION
Neuropeptides are evolutionarily ancient mediators of neuronal
signaling in nervous systems that have fundamental roles in reg-
ulation of physiological processes and animal behavior. They are
remarkably diverse, ranging from 3 to >40 residues, but all are
derived from larger precursor proteins. Some neuropeptide pre-
cursors are simple, giving rise to a single neuropeptide, while
others yield multiple related or unrelated neuropeptides (1–3).
A major challenge in neurobiology is to understand the evo-
lutionary and functional significance of neuropeptide diversity
in animals. Determining evolutionary relationships between neu-
ropeptides in different phyla has proven to be difficult because they
comprise relatively short stretches of amino acids, often with only
a few conserved residues. However, recent advances in comparative
genomics/transcriptomics are transforming our understanding of
neuropeptide signaling systems. Thus, a picture is emerging of a
core set of neuropeptide–receptor signaling pathways that can be
traced back to the common ancestor of the Bilateria, with neu-
ropeptide orthologs being identified in an increasingly wide range
of animal phyla (4–8).
In this review, our attention is focused on neuropeptides that
are unified by a common structural characteristic – the presence
of a C-terminal Arg–Phe–NH2 (RFamide) motif. In vertebrates,
five types of RFamides have been identified, which are derived
from different precursor proteins: (1) Gonadotropin-inhibitory
hormone (GnIH)-type, (2) Neuropeptide FF (NPFF)-type, (3)
Pyroglutamated RFamide peptide (QRFP)-type, (4) Prolactin-
releasing peptide (PrRP)-type, and (5) Kisspeptin-type (9, 10).
Here, we briefly review how these diverse RFamides were discov-
ered and then we proceed to our main objective – to explore the
phylogenetic distribution and evolutionary origins of these neu-
ropeptides. Our primary focus will be on deuterostomian inver-
tebrates (urochordates, cephalochordates, hemichordates, and
echinoderms) because these animals share a more recent common
ancestor with vertebrates than the protostomian invertebrates
(e.g., arthropods, nematodes, annelids, and mollusks) (11). How-
ever, in reviewing research on RFamides, the story begins (and
ends) with what at first sight might be considered an inauspicious
protostomian invertebrate – the sunray venus clam Macrocallista
nimbosa, a bivalve mollusk.
FMRFamide – THE PROTOTYPICAL RFamide-TYPE
NEUROPEPTIDE
The tetrapeptide Phe–Met–Arg–Phe–NH2 (FMRFamide) was
purified from extracts of ganglia from the clam Macrocallista nim-
bosa on account of its cardioexcitatory activity. A chromatograph-
ically distinct component of molluscan ganglia that stimulates
beating of quiescent molluscan hearts, known as peak C, was
first reported in 1967 (12). Ten years later Price and Greenberg
identified peak C as FMRFamide, reporting their finding in the
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journal Science (13). FMRFamide might have remained an obscu-
rity of molluscan pharmacology were it not for the discovery that
FMRFamide-like peptides occur throughout the animal kingdom.
For example, using antibodies to FMRFamide, cross-reacting pep-
tides were detected immunocytochemically in the nervous systems
of an insect, a fish, and a mammal (14). And so began an era
in which neuropeptides that share a C-terminal RFamide motif
with FMRFamide were identified in a wide range of taxa, includ-
ing cnidarians, nematodes, insects, and vertebrates (15, 16). A
comprehensive survey of the diverse set of RFamide-type neu-
ropeptides that have been identified in the animal kingdom is
beyond the scope of this review, where the focus is on RFamides
that were first discovered in vertebrates. However, we will take on a
broader phylogenetic perspective in the last section of this review,
highlighting, for example, RFamide-type neuropeptides that have
ancient bilaterian origins but which have been lost in the vertebrate
lineage.
FROM LPLRFamide TO GnIH: THE BIRD BRAIN’S
CONTRIBUTION TO RFamide DISCOVERY IN VERTEBRATES
The first RFamide-type neuropeptide to be identified in a verte-
brate was purified from chicken brain extracts on account of its
cross-reactivity with antibodies to FMRFamide. Reporting in the
journal Nature in 1983, the purified peptide was identified as the
pentapeptide Leu–Pro–Leu–Arg–Phe–NH2 (LPLRFamide) (17).
Seventeen years later, using antibodies to RFamide, an RFamide-
type neuropeptide was purified from quail brain extracts and iden-
tified as the dodecapeptide SIKPSAYLPLRFamide (18). Therefore,
it is likely that the LPLRFamide peptide originally isolated from
chicken brain was a fragment of a homolog of this dodecapeptide.
Investigation of the physiological roles of SIKPSAYLPLRFamide
has revealed that it inhibits pituitary release of gonadotropic hor-
mones – hence this peptide was named GnIH. The GnIH precursor
contains two related peptides known as GnIH-RP1 and GnIH-
RP2, which have the C-terminal motif LPxRFamide (where x is L
or Q) (19). Importantly, GnIH-like neuropeptides that suppress
reproductive activity have also been identified in mammals (20,
21). Furthermore, the orphan receptor GPR147 has been iden-
tified as the G-protein coupled receptor that mediates effects of
GnIH-type neuropeptides. GPR147 is also now known as NPFFR1
or NPFF1 (22–24).
Analysis of the phylogenetic distribution of GnIH-type neu-
ropeptides has revealed that they occur throughout the verte-
brates, from primitive agnathan vertebrates through bony fish
and amphibians to reptiles, birds, and mammals (25, 26). A com-
prehensive survey of the properties and functions of GnIH-type
neuropeptides in each of the vertebrate classes is beyond the scope
of this review and has been discussed elsewhere. Therefore, we
will focus here on studies in the most primitive extant vertebrates,
the agnathans (lamprey, hagfish). A cDNA encoding a precursor
of two GnIH-type peptides has been identified in the sea lamprey
Petromyzon marinus, with expression revealed in the hypothala-
mus and gonads (26). Interestingly, injection of the GnIH-type
peptides stimulates expression of GnRH and gonadotropins in
lamprey, which contrasts with the inhibitory effects of GnIH in
birds and mammals. Thus, the physiological role of GnIH as a reg-
ulator of reproductive processes can be traced back to the common
ancestor of vertebrates, but inhibitory or stimulatory effects are
observed in different vertebrate lineages (26).
F8Fa (NPFF) AND A18Fa (NPAF): BOVINE FMRFamide-LIKE
IMMUNOREACTIVE PEPTIDES AND PROTOTYPES FOR THE
NEUROPEPTIDE FF FAMILY
The first RFamides to be identified in mammals were purified from
extracts of bovine brain, employing antibodies to FMRFamide
in a radioimmunoassay. Two neuropeptides were identified:
FLFQPQRFamide (F8Fa or NPFF) and AGEGLSSPFWSLAAPQR-
Famide (A18Fa or NPAF), which have a common C-terminal
motif – PQRFamide (27). Subsequently, it has been found that
these peptides are derived from the same precursor protein (28,
29) and exert effects by binding to the G-protein coupled receptor
GPR74, which is also referred to as NPFFR2 or NPFF2 (22, 24, 30).
Early on it was found that NPFF and NPAF attenuate
morphine-induced antinociception and cause hyperalgesia (27);
consistent with these effects, NPFF2 receptors are expressed in the
dorsal horn of the spinal cord (31). However, evidence of roles
in regulation of other physiological processes has been obtained
subsequently; for example, increasing blood pressure and slowing
heart rate (32–34).
Analysis of the phylogenetic distribution of NPFF/NPAF-type
neuropeptides has revealed that they occur throughout the ver-
tebrates, from primitive agnathan vertebrates through bony fish
and amphibians to reptiles, birds, and mammals (35). For exam-
ple, in the agnathan P. marinus (sea lamprey) a cDNA encoding
a precursor protein that gives rise to three neuropeptides with
a C-terminal PQRFamide motif has been identified (36). The
PQRFamide-type precursor is expressed in several regions of
the lamprey brain, including the hypothalamus, mesencephalon,
and medulla oblongata (36). Interestingly, in vivo pharmacolog-
ical tests have revealed that one of the PQRFamide-type pep-
tides triggers increased expression of GnRH-II in the lamprey
(37). In hagfish, there are two PQRFamide-type precursors and
in vitro tests with one of the derived PQRFamide-type peptides
revealed stimulation of gonadotropin expression in the hagfish
pituitary (35).
RFamides AS LIGANDS FOR ORPHAN G-PROTEIN COUPLED
RECEPTORS: DISCOVERY OF QRFP, PrRP, AND KISSPEPTIN
By the late 1990s, a growing number of orphan G-protein cou-
pled receptors had been cloned and sequenced on account of their
similarity with known receptors. And so began an era in which
the search for endogenous ligands for these receptors became
a priority and between 1998 and 2003, three novel types of
RFamide neuropeptides were discovered in this period of receptor
de-orphanization or “reverse pharmacology” (38, 39).
QRFP
In 2003, the endogenous ligand for the orphan receptor GPR103
was identified as a 26-residue peptide with a C-terminal RFamide
motif, which is known pyroglutamylated arginine–phenylalanine-
amide peptide (QRFP) or 26RFa (40–42). Subsequent studies
have revealed that QRFP is expressed in regions of the hypo-
thalamus involved in control of feeding behavior and accordingly
pharmacological studies have revealed that this peptide increases
intake of a high fat diet (43–46).
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Analysis of the phylogenetic distribution of QRFP-type neu-
ropeptides has revealed that they occur throughout the vertebrates,
from bony fish and amphibians to reptiles, birds, and mam-
mals (47, 48). The occurrence of QRFP-type neuropeptides in
agnathans has, as yet, not been reported; however, notwithstanding
secondary loss, it is expected because the phylogenetic distrib-
ution of QRFP-type neuropeptides extends to invertebrates [see
Figure 2B; (8)] and because a QRFP-type receptor is present
in lamprey (48). Investigation of the physiological roles of the
QRFP-type neuropeptide in a teleost species, the goldfish Caras-
sius auratus, revealed that injection of synthetic QRFP caused an
increase in serum gonadotropins, but only at the highest dose of
QRFP tested (1µg/g body weight). Interestingly, upregulation of
hypothalamic QRFP precursor mRNA expression was observed
following 4 days of food deprivation in goldfish, indicating that
QRFP-type neuropeptides may have an evolutionarily ancient role
in regulation of food intake in vertebrates (47). Further studies are
now needed to investigate more widely the physiological roles of
QRFP-type neuropeptides in non-mammalian vertebrates.
PrRP
In 1998, endogenous ligands for the orphan receptor GPR10 were
isolated from hypothalamic extracts and identified as a 31-residue
peptide with a C-terminal RFamide motif and a N-terminally
truncated 20-residue isoform of the 31-residue peptide. Investi-
gation of the physiological roles of these peptides revealed that
they stimulate release of prolactin from anterior pituitary cells
and hence, they were named PrRPs (49). However, the physiolog-
ical relevance of this in vitro effect of PrRPs has been questioned
and alternative roles in regulation of feeding and stress hormone
release have been proposed (50, 51).
Analysis of the phylogenetic distribution of PrRP-type neu-
ropeptides has revealed that they occur throughout the vertebrates
from primitive agnathans (52) to bony fish and tetrapods [(53);
Figure 2C]. Interestingly, phylogenomic analysis has led to the
proposal that PrRP and its cognate receptor originated from
the neuropeptide Y (NPY) peptide-receptor system following the
genome duplications that occurred during the early evolution of
vertebrates (53). Thus, the evolution and physiological roles of
PrRP-type peptides needs to be considered in the context of a
bilaterian family of neuropeptides that includes NPY in verte-
brates (C-terminal RYamide motif) and invertebrate neuropeptide
F (NPF)-type peptides, which have a C-terminal RFamide motif
[(54); see also below for further discussion of this topic].
Comparative analysis of the physiological roles of PrRP-type
peptides has revealed that PrRP-type peptides stimulate prolactin
release in bony fish (55), indicating that this is an ancient role in
vertebrates. Furthermore, evidence of roles for PrRP-type peptides
in regulation of feeding behavior and growth hormone release in
non-mammalian vertebrates has been obtained (52, 56).
KISSPEPTIN
In 2001, the endogenous ligands for the orphan receptor GPR54
were identified as a 54-residue peptide with a C-terminal RFamide
motif and N-terminally truncated isoforms of the 54-residue pep-
tide comprising 13 or 14 residues. It was discovered that these pep-
tides are derived from metastasis-suppressor protein KiSS-1 and
hence they were named kisspeptins (57). Subsequently, evidence
that kisspeptins are important physiological regulators of repro-
ductive development was obtained. Thus, loss-of-function muta-
tions in the kisspeptin receptor (GPR54) cause a failure to progress
through puberty due to hypogonadotropic hypogonadism (58).
Analysis of the phylogenetic distribution of kisspeptins has
revealed homologs throughout the vertebrates, from agnathans
to mammals (59). Furthermore, in some vertebrates up to three
genes encoding precursors of kisspeptins have been found; for
example, in the coelacanth, a sarcopterygian fish, and the ele-
phant shark, a chondrichthyan fish. Accordingly, multiple copies
of candidate kisspeptin receptors are found in some vertebrates;
for example, in the coelacanth and the spotted gar (an actinoptery-
gian fish), there are four genes encoding kisspeptin-type receptors
and phylogenomic analysis indicates this reflects the two rounds
of whole genome duplication that are thought to have occurred
in a basal ancestral vertebrate (60). However, in the majority of
vertebrates there has been loss of one or more kisspeptin precur-
sor and kisspeptin receptor paralogs. For example, in the zebrafish
Danio rerio there are two kisspeptin precursors (61), while the
most extreme loss is seen in some bird species where no genes
encoding a kisspeptin precursor or kisspeptin receptor have been
found (62). Investigation of the physiological roles of kisspeptins
in non-mammalian vertebrates indicates that the kisspeptin sig-
naling system has an ancient role in regulation of reproductive
development (63).
THE PHYLOGENETIC DISTRIBUTION AND EVOLUTIONARY
ORIGINS OF VERTEBRATE RFamide-TYPE NEUROPEPTIDES:
INSIGHTS FROM DEUTEROSTOMIAN INVERTEBRATES
Orthologs of receptors for vertebrate RFamide-type neuropeptides
occur in deuterostomian and protostomian invertebrates (8), as
illustrated in Figure 1. Thus, based on this phylogenetic distribu-
tion, the evolutionary ancestry of NPFF/GnIH-type, QRFP-type,
and kisspeptin-type receptors can be traced back to the com-
mon ancestor of the bilaterians. The PrRP receptor is an excep-
tion in as much as orthologs of this receptor are only found in
deuterostomes.
The discovery of invertebrate orthologs of vertebrate recep-
tors for RFamide-type neuropeptides is fascinating because it
provides a basis for discovery of ligands for these receptors and
investigation of their physiological roles in invertebrates. An
example of where this has been accomplished is the discovery
that SIFamide-type neuropeptides are ligands for protostomian
orthologs of NPFF/GnIH-type receptors (64). SIFamides share
limited sequence similarity with vertebrate NPFF/GnIH-type neu-
ropeptides (Figure 2A); however, analysis of the physiological roles
of SIFamide in Drosophila indicates that it acts to suppress repro-
ductive behavior (65). This is intriguing because it is consistent
with the role of GnIH as an inhibitory regulator of reproductive
processes in vertebrates (20). Thus, it appears that the evolution-
ary origin of GnIH/SIFamide-type neuropeptides as reproductive
inhibitors may trace back to the common ancestor of the Bilateria
(66).
Little is known about the molecular identity of peptide lig-
ands for invertebrate orthologs of other vertebrate RFamide-type
receptors. Therefore, here we have addressed this issue, focusing on
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FIGURE 1 | Phylogenetic analysis of bilaterian rhodopsin β-type (A) and
rhodopsin γ-type (B) receptors. The red arcs highlight four groups that
include receptors that are known to be activated by RFamide-type peptides.
These include a large group of receptors for QRFP (pyroglutamylated
RFamide peptide), SIFa (SIFamide), NPFF (Neuropeptide FF and
Gonadotropin-inhibitory hormone), PrRP (Prolactin-releasing peptide),
NPY/NPF (Neuropeptide Y/F), sNPF (short Neuropeptide F), and Luqin, and
two isolated groups of RFamide-type receptors, CCK/SK
(Cholecystokinin/Sulfakinin), and Kiss1 (Kisspeptin) receptors. In
(A) rhodopsin α-type receptors (photoreceptors and aminergic receptors)
are included as an outgroup. The prefixes b-, d-, p- designate subgroups of,
respectively, bilaterian, deuterostomian, and protostomian receptors.
Deuterostomian and protostomian clades have been colored in pink and
blue, respectively. Gray sections of the trees correspond to groups of
receptors for which either only deuterostomian or protostomian ligands are
known. The fact that most of the rhodopsin β-type RFamide receptors fall in
the same region of the tree suggests that these probably originated from a
common ancestral RFamide-type neuropeptide signaling system. However,
the occurrence of other groups of receptors that are activated by RFamides
(CCK, Kiss1) indicates that RFamide-type neuropeptides have evolved
independently at least three times in bilaterian history. Figure adapted from
Ref. (8).
deuterostomian invertebrates. These include two sub-phyla of the
phylum Chordata – the urochordates [e.g., the sea squirt Ciona
intestinalis; (67)] and the cephalochordates [e.g., Branchiostoma
floridae; (68)]. Other deuterostomian phyla are the hemichordates
[e.g., acorn worm Saccoglossus kowalevskii; (69)] and the echino-
derms [e.g., the sea urchin Strongylocentrotus purpuratus (70)],
which are sister phyla in a clade of deuterostomian invertebrates
known as the ambulacraria (11).
GnIH/NPFF-TYPE NEUROPEPTIDES IN DEUTEROSTOMIAN
INVERTEBRATES
Orthologs of GnIH/NPFF-type receptors are not present in the
sea squirt C. intestinalis and therefore, it appears that this neu-
ropeptidergic system has been lost in the urochordate lineage. In
the cephalochordate B. floridae, there is an expanded family of
GnIH/NPFF-type receptors (8) and accordingly at least two pre-
cursors of putative peptide ligands for these receptors have been
identified, with the predicted neuropeptide products sharing a
common C-terminal PxRFamide motif (where x is variable) with
vertebrate GnIH/NPFF-type neuropeptides [(8); Figure 2A].
GnIH/NPFF-type neuropeptides in vertebrates can be divided
into two functional groups – peptides that are PQRFamides, which
modulate nociception (28) and LRFamides, which inhibit the
release of gonadotropins (19). Peptides derived from both of the
GnIH/NPFF-type precursors in B. floridae are LRFamides, sug-
gesting that the ancestral GnIH/NPFFamide-type neuropeptides
in chordates were LRFamides that may have had a role in regulation
of reproduction. Furthermore, the LxFamide motif is conserved in
lophotrochozoan (e.g., Capitella and Lottia) SIFamide-type pep-
tides, suggesting that a leucine at position-2 relative to a C-terminal
amidated phenylalanine and a role in reproduction are ancient
characteristics of this family of orthologous peptides.
As highlighted above, SIFamide-type neuropeptides have been
identified as ligands for GnIH/NPFF-type receptors in proto-
stomian invertebrates. However, SIFamides share very limited
sequence similarity with chordate GnIH/NPFF-type peptides; in
fact the only universally shared feature is a C-terminal Phe–NH2
motif (Figure 2A), although this does extend to Leu–x–Phe–NH2
in some cases. Thus, when comparing chordate GnIH/NPFF-type
peptides and protostomian SIFamides, sequence divergence has
rendered the orthologous relationship between these peptides
almost completely unrecognizable. In this context, it would be
interesting to identify putative ligands for GnIH/NPFF/SIFamide-
type receptors in non-chordate deuterostomes.
Recently, it was proposed that SALMFamide-type neuropep-
tides may be echinoderm homologs of GnIH/NPFF/SIFamide-
type neuropeptides (66). The rationale for this hypothesis was
that L-type SALMFamides share sequence similarity with some
SIFamides – in particular, the C-terminal SxLxFamide motif.
However, we have not obtained support for this hypothesis from
analysis of the occurrence of GnIH/NPFF/SIFamide-type recep-
tors in echinoderms. Thus, orthologs of GnIH/NPFF/SIFamide-
type receptors do not appear to be present in the sea urchin
S. purpuratus (8). Therefore, the sequence similarity shared
by SALMFamides and some SIFamides may reflect conver-
gence and it appears, based on the data currently available,
that GnIH/NPFF/SIFamide-type neuropeptide signaling may have
been lost in the echinoderm lineage.
Frontiers in Endocrinology | Neuroendocrine Science June 2014 | Volume 5 | Article 93 | 4
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Elphick and Mirabeau Evolution of RFamide-type neuropeptides
FIGURE 2 | Alignment of known orthologous peptides from
(A) bilaterian NPFF/SIFa (B), chordate QRFP, (C) vertebrate PrRP, and (D)
chordate kisspeptin families. The names of deuterostomian and
protostomian peptides are shaded in pink and blue, respectively. The
C-terminal amide groups are represented by an “a” at the end of aligned
sequences. The lamprey sequences are from Ref. (26), other vertebrate and
B. floridae sequences are from Ref. (8), the Lottia gigantea sequences are
from Ref. (4), and the Capitella teleta sequence is from Ref. (5). For
vertebrate sequences, only one peptide from each precursor is shown in the
alignment. Genbank (GI) or JGI IDs of all precursor sequences are listed
below: (A) alignment of chordate NPFF/SIFa peptides: Hsap_GnIH, Homo
sapiens GnIH (GI:11125707); Hsap_NPFF, Homo sapiens NPFF precursor
(GI:219878493); Drer_GnIH, Danio rerio GnIH precursor (GI:283825363),
Danio rerio NPFF precursor (GI:116078056); Pmar1, Petromyzon marinus
NPFF/GnIH precursor 1 (GI:88595366); Pmar2, Petromyzon marinus
NPFF/GnIH precursor 2 (GI:374849285); Bflo1, Branchiostoma floridae
NPFF/GnIH precursor 1 (GI:260808912); Bflo2_1–7, Branchiostoma floridae
NPFF/GnIH precursor 2 (GI:260829186); Lgig1, Lottia gigantea SIFamide
precursor 1 (JGI: 176362); Lottia gigantea SIFamide precursor 2 (JGI:
175046); Ctel, Capitella teleta SIFamide precursor (GI:161198869); Tcas,
Tribolium castaneum SIFamide precursor (GI:189239683); Dmel_SIFa,
Drosophila melanogaster SIFamide precursor (GI:386768581); Dpul,
Daphnia pulex SIFamide precursor (JGI: 260818); Cele, Caenorhabditis
elegans SIFamide precursor (GI:392894563). (B) Alignment of chordate
QRFP peptides: Hsap, Homo sapiens pyroglutamylated RFamide peptide
precursor (GI:38016139); Oana Ornithorhynchus anatinus QRFP precursor
(GI:620943939); Drer, Danio rerio QRFP precursor (GI:528509692); Bflo1–3,
Branchiostoma floridae QRFP precursors (GI:260828082, GI:260828080,
and JGI:107075). (C) Alignment of vertebrate PrRP peptides: Hsap, Homo
sapiens prolactin-releasing peptide/hormone (GI:7705679); Drer1-2, Danio
rerio prolactin-releasing peptide precursors (GI:350539516, GI:528519441);
Pmar, Petromyzon marinus prolactin-releasing peptide precursor (Ensembl
scaffold: GL490889). (D) Alignment of Kisspeptins: Hsap_Kisspep-14, Homo
sapiens KiSS-1 metastasis-suppressor precursor (GI:116829963); Drer1-2,
Danio rerio KiSS-1 precursors (GI:157061759, GI:217272819); Pmar,
Petromyzon marinus KiSS-1 precursors (GENSCAN00000116455); Bflo1-4,
Branchiostoma floridae KiSS-1 precursors (GI:260826607, GI:260793233,
GI:260826605, and GI:260827077).
The hemichordates are a sister phylum to the echinoderms
and a GnIH/NPFF-type receptor has been identified in the acorn
worm S. kowalevskii (8). Therefore, the presence of a gene encod-
ing a GnIH/NPFF-type neuropeptide precursor is anticipated, but
it remains to be discovered. If the endogenous ligand for the
GnIH/NPFF/SIFamide-type receptor in S. kowalevskii is identi-
fied, it would be fascinating to investigate the physiological roles of
this peptide. Does it, for example, act as an inhibitor of reproduc-
tive processes in S. kowalevskii? – a role that would be consistent
with the physiological roles of GnIH and SIFamide in vertebrates
and Drosophila, respectively.
QRFP-TYPE NEUROPEPTIDES IN DEUTEROSTOMIAN
INVERTEBRATES
Orthologs of vertebrate QRFP-type receptors are present in the
cephalochordate B. floridae, the hemichordate S. kowalevskii, the
echinoderm S. purpuratus, and in lophotrochozoan protostomes
but not in urochordates or ecdysozoan protostomes (8). Thus, the
evolutionary origin of the QRFP-type peptide signaling system can
be traced back to the common ancestor of the Bilateria but with
subsequent loss in ecdysozoan protostomes and urochordates.
Three precursors of candidate ligands for QRFP-type recep-
tor(s) have been identified in B. floridae. Like most QRFP-type
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neuropeptides in vertebrates, all three peptides are predicted to
comprise 25 residues with a C-terminal RFamide motif. Other
features in common with vertebrate QRFP-type neuropeptides
include a conserved leucine residue at position four, a conserved
alanine residue at position eight, a conserved lysine residue at
position 18, and a conserved glycine residue at position 20 [(8);
Figure 2B].
QRFP-type receptors are present in echinoderms (S. purpura-
tus) and hemichordates (S. kowalevskii) (8); Table S1 in Supple-
mentary Material) but precursors of QRFP-type peptides have as
yet not been identified in these phyla. It has been noted though
that F-type SALMFamide neuropeptides in echinoderms are sim-
ilar to vertebrate QRFP-type peptides in having a C-terminal
FxFamide motif (where x is variable) (71). However, the orga-
nization of F-type SALMFamide precursors is different from that
of QRFP-type precursors because they comprise multiple copies of
shorter peptides, ranging in length from seven to twenty residues
(72). This contrasts with QRFP-type precursors that have been
identified in chordates, which comprise a single copy of a 25-
residue peptide (Figure 2B). More extensive analysis of echino-
derm and hemichordate genome/transcriptome sequence data is
now required to investigate the existence of precursors of QRFP-
type peptides in these non-chordate deuterostomian invertebrates.
Likewise, QRFP-type receptors are present in lophotrochozoan
protostomes (8) but candidate peptide ligands for these receptors
have yet to be identified. If this can be accomplished, then com-
parative functional analysis of QRFP-type peptides in a variety of
invertebrates would provide fascinating insights into the origins
and evolution of the physiological roles of this ancient bilaterian
neuropeptidergic signaling system.
PrRP-TYPE NEUROPEPTIDES IN DEUTEROSTOMIAN
INVERTEBRATES
Orthologs of vertebrate PrRP-type receptors are present in the
cephalochordate B. floridae and the hemichordate S. kowalevskii
but not in urochordates, echinoderms, or protostomes (8). We
have identified one and three PrRP-type receptors in the hemi-
chordate S. kowalevskii and the cephalochordate B. floridae, respec-
tively, but analysis of genome/transcriptome data for these species
has thus far not yielded candidate precursors of peptide ligands for
these receptors [(8); Table S1 in Supplementary Material]. Never-
theless, the existence of PrRP-type receptors in B. floridae and S.
kowalevskii indicates that the duplication of a NPY-type recep-
tor gene and a NPY-type precursor gene that is proposed to have
given rise to the PrRP peptide-receptor system occurred earlier
in animal evolution than has been proposed previously (53). Our
data indicate that these gene duplications occurred in a common
ancestor of deuterostomes, with subsequent loss in urochordates
and echinoderms.
KISSPEPTIN-TYPE NEUROPEPTIDES IN DEUTEROSTOMIAN
INVERTEBRATES
Orthologs of vertebrate kisspeptin-type receptors are present in
the cephalochordate B. floridae, the hemichordate S. kowalevskii,
the echinoderm S. purpuratus, and in lophotrochozoan proto-
stomes but not in urochordates or ecdysozoan protostomes [(8);
Table S1 in Supplementary Material]. Based on these findings,
the evolutionary origin of kisspeptin-type peptide signaling can
be traced back to a common ancestor of the Bilateria but with
subsequent loss in urochordates and ecdysozoan protostomes.
In B. floridae, an expanded family of 16 kisspeptin-type recep-
tors and 4 precursors of kisspeptin-like peptides have been iden-
tified [(8); Figure 2D; Table S1 in Supplementary Material]. One
of the precursors (Bflo1; GI:260826607) contains a peptide with
a putative C-terminal RFamide motif, in common with verte-
brate kisspeptins (Figure 2D). Another kisspeptin-type precursor
(Bflo4; GI:260827077) gives rise to peptides with putative C-
terminal VFamide, SFamide, and PFamide motifs and two paral-
ogous precursors (Bflo2; GI:260793233 and Bflo3; GI:260826605)
yield peptides with a C-terminal Wamide and Hamide, respec-
tively. However, features that are conserved between all chordate
kisspeptins are two conserved asparagine residues located seven
or eight, and five or six residues from the C-terminal amidated
residue (Figure 2D) and a conserved phenylalanine or trypto-
phan located three or four residues from the C-terminal amidated
residue (Figure 2D).
Hitherto, kisspeptin-type peptides have only been identified
in chordates (8). However, the occurrence of kisspeptin-type
receptors in S. kowalevskii and S. purpuratus (8) indicates that
kisspeptin-type peptides may exist in hemichordates and echin-
oderms. Likewise, the presence of kisspeptin-type receptors in
lophotrochozoan invertebrates indicates that kisspeptin-type pep-
tides may exist in these animals, but they remain to be discovered.
If kisspeptin-type peptides can be identified in ambulacrarians
(hemichordates and echinoderms) and lophotrochozoans (e.g.,
mollusks and annelids) then investigation of their functions in
these animals may provide insights into the ancestral physiological
roles of kisspeptins in the common ancestor of bilaterians.
OTHER RFamide-TYPE NEUROPEPTIDES IN BILATERIANS
The primary focus of this review has been on neuropeptide fam-
ilies where vertebrate representatives have a C-terminal RFamide
motif. However, there are also other bilaterian neuropeptide fam-
ilies that include RFamide-type peptides but where vertebrate
representatives have either lost this feature or have been lost alto-
gether. Furthermore, some RFamide-type neuropeptides appear
to have evolved only within the protostomian lineage. Below, we
briefly discuss some examples and in so doing illustrate that in
characterizing neuropeptides as “RFamides,” the representatives
of different neuropeptides families that are assembled may vary
depending on the phylogenetic perspective taken.
NPY/NPF-TYPE NEUROPEPTIDES
NPY-type neuropeptides include the mammalian peptides neu-
ropeptide Y (NPY), pancreatic polypeptide (PP), and peptide YY
(PYY), which have a C-terminal RYamide motif (73). However,
some representatives of this family in non-mammalian vertebrates
have a C-terminal RFamide motif – e.g., alligator PP (74). An
NPY-type neuropeptide in the cephalochordate B. floridae also
has a C-terminal RYamide motif but the NPY-type neuropep-
tide in the hemichordate S. kowalevskii has a C-terminal RFamide
motif (8). Protostomian orthologs of the NPY family are char-
acterized by a C-terminal RFamide motif and hence are named
NPF (54) (Figure 3A). Thus, it appears that in the NPY/NPF-type
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FIGURE 3 | Alignment of known orthologous peptides from (A) bilaterian
NPY/NPF, (B) bilaterian Cholecystokinin/Gastrin (CCK), and (C) bilaterian
Luqin/RYamide families. The names of deuterostomian and protostomian
peptides are shaded in pink and blue, respectively. The C-terminal amide
groups are represented by an “a” at the end of aligned sequences. Skow
Luqin is from Ref. (7), Spur Luqin is from Ref. (75), and Tcas Luqin/RYamide is
from Ref. (76). The Lottia gigantea sequences are from Ref. (4), the Capitella
teleta sequences are from Ref. (5), and other sequences are from Ref. (8). For
vertebrate sequences, only one peptide from each precursor is shown in the
alignment. Genbank (GI) or JGI IDs of all precursor sequences are listed
below: (A) Alignment of bilaterian NPY/F-type peptides: Hsap_NPY,
Hsap_PYY, and Hsap_PAHO; Homo sapiens Neuropeptide Y, Peptide Tyrosine
tyrosine, and Pancreatic polypeptide precursors (GI:189273, GI:300068955,
and GI:35589); Pmar_NPY, Petromyzon marinus Neuropeptide Y precursor
(GI:57231270); Bflo, Branchiostoma floridae NPY-like precursor
(GI:260829184); Skow, Saccoglossus kowalevskii NPY-like precursor
(GI:585716458); Ctel1-2, Capitella teleta NPF precursors (GI:161315271,
JGI:204022); Lgig, Lottia gigantea NPF precursor (GI:163562021); Dpul,
Daphnia pulex NPF precursor (GI:168841503); Dmel, Drosophila
melanogaster NPF precursor (GI:442619467). (B) Alignment of bilaterian
Cholecystokinin/Sulfakinin-type peptides: Hsap, Homo sapiens CCK precursor
(GI:84040232); Drer, Danio rerio CCK-like precursor (GI:42490839); Pmar,
Petromyzon marinus CCK-like precursor (GI:299891581); Cint, Ciona
intestinalis CCK-like (Cionin) precursor (GI:296983); Skow1-2, Saccoglossus
kowalevskii CCK-like precursors (GI:585688033, GI:187061456); Spur,
Strongylocentrotus purpuratus CCK-like precursor (GI:390355380); Ctel,
Capitella teleta Sulfakinin (SK)-type precursor (GI:161296032); Lgig, Lottia
gigantean SK-type precursor (GI:163526260); Dpul, Daphnia pulex SK-type
precursor (JGI:242979); Dmel, Drosophila melanogaster SK-type precursor
(GI:386765036). (C) Alignment of bilaterian Luqin-type peptides: in addition to
the luqin sequences, which are followed by a dibasic cleavage site (CS), the
sequences of a conserved cysteine-containing C-terminal domain of the
precursor proteins are also shown. The residues connecting the two domains
are not represented. Skow, Saccoglossus kowalevskii Luqin-like precursor
(GI:187205184); Spur, Strongylocentrotus purpuratus Luqin-type precursor
(GI:390331827); Apom, Alvinella pompejana Luqin-type precursor
(GI:223786475), Lgig, Lottia gigantea, Luqin-type precursor (GI:163510328);
Dpul, Daphnia pulex, RYamide-type precursor (JGI:251691); Tcas, Tribolium
castaneum, RYamide-type precursor (GI:347807413); Isca, Ixodes scapularis
RYamide-type precursor (GI:156462907).
neuropeptide family the C-terminal RYamide motif is a derived
characteristic of the chordates and the ancestral motif in the
common ancestor of bilaterians was probably RFamide. Also of
relevance here are the PrRP-type neuropeptides in mammals and
other vertebrates, one of five families of RFamide-type peptides
discussed above, which are thought to have arisen by duplication
of a gene encoding an NPY/NPF-type precursor in a common
ancestor of the deuterostomes (see above). Thus, when taking
a bilaterian phylogenetic perspective, the NPY/NPF-type family
of neuropeptides can be considered as members of the het-
erogeneous assemblage of neuropeptides that are categorized as
RFamides.
CCK/GASTRIN-TYPE NEUROPEPTIDES
Cholecystokinin (CCK) and gastrin are gut hormones/neuro-
peptides in mammals and other vertebrates that share a common
C-terminal motif – GWMDFamide (77, 78) (Figure 3B). Fur-
thermore, a CCK/gastrin-type neuropeptide identified in the uro-
chordate C. intestinalis also has this motif (79). However, the first
invertebrate representatives of the CCK/gastrin family to be iden-
tified were the sulfakinins (SKs), which have been isolated from
several insect species, and these neuropeptides have a C-terminal
RFamide motif (80, 81). In the nematode C. elegans, CCK/gastrin-
type peptides have a C-terminal QFamide motif (82); however,
this is probably a derived feature because CCK/gastrin-type pep-
tides in lophotrochozoan protostomes (e.g., annelids, mollusks)
are like the insect SKs in having a C-terminal RFamide motif
(4, 5, 8) (Figure 3B). Thus, from a protostomian perspective
CCK/gastrin-type neuropeptides are RFamides.
CCK/gastrin-type neuropeptide precursors have recently been
identified in non-chordate deuterostomian invertebrates, provid-
ing important new insights on the evolution of this neuropeptide
www.frontiersin.org June 2014 | Volume 5 | Article 93 | 7
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Elphick and Mirabeau Evolution of RFamide-type neuropeptides
family. In the hemichordate S. kowalevskii, there is a CCK/gastrin-
type precursor, which gives rise to three putative peptides that have
the C-terminal motifs GTLFamide,GTTFamide and GMMFamide
[(8); Figure 3B], while in the echinoderm S. purpuratus, there is a
CCK/gastrin-type precursor that gives rise to three putative pep-
tides that have the C-terminal motifs GMFFamide, GMWFamide
and GGFFamide [(8); Figure 3B]. Thus, these ambulacrarian
CCK/gastrin-type peptides do not have a C-terminal RFamide
motif and therefore, it appears that only the C-terminal Famide
motif is a common feature that is found in both protostomian and
deuterostomian CCK/gastrin-type peptides (Figures 3B and 4).
LUQINS
Luqin is an RFamide-type neuropeptide (APSWRPQGRFamide)
that was originally isolated from the mollusk Aplysia californica
and named luqin because it is expressed in the dorsal left upper
quadrant (LUQ) cells of the abdominal ganglion in this species
(83). Subsequently, luqin-type neuropeptides with a C-terminal
RFamide motif have been identified in other molluscan species and
in annelids (4, 5), while members of the luqin family in arthropods
and nematodes are characterized by a C-terminal RYamide motif
and hence are referred to as RYamides (8, 76) (Figure 3C). Luqin-
type neuropeptides have also been identified in hemichordates
and echinoderms and these peptides have a C-terminal RWamide
motif (7, 75) (Figure 3C). However, luqin-type neuropeptide
signaling has been lost in the chordate lineage (8).
Thus, in conclusion, the luqins are a bilaterian neuropeptide
family but only from a lophotrochozoan perspective are they
RFamide-type neuropeptides.
FMRFamide-RELATED NEUROPEPTIDES IN PROTOSTOMES
Last but not least, we return to where the RFamide story began –
with the tetrapeptide FMRFamide that was isolated from mollus-
can ganglia in 1977 (13). FMRFamide-related peptides that share
with FMRFamide a C-terminal FxRFamide motif have been iden-
tified throughout the protostomes (15, 16) but not in deuteros-
tomes. Thus, it appears that neuropeptides with the C-terminal
FMRFamide-type motif FxRFamide are a uniquely protostomian
invention.
THE RFamide MOTIF: AN ANCIENT AND A CONVERGENT
FEATURE OF NEUROPEPTIDE EVOLUTION
A primary objective here was to review evidence of the occurrence
of RFamide-type peptides and their receptors in deuterostomian
invertebrates and a summary of our findings is shown in Figure 4
and in a complementary supplementary table. With an anthro-
pocentric perspective, the main focus of this review has been
on five types of RFamide neuropeptides that are found in ver-
tebrates: (1) Gonadotropin-inhibitory hormone (GnIH)-type, (2)
NPFF-type, (3) Pyroglutamated RFamide peptide (QRFP)-type,
(4) Prolactin-releasing peptide (PrRP)-type, and (5) Kisspeptin-
type. Four of these neuropeptide types, GnIH, NPFF, QRFP, and
PrRP, exert their effects via receptors that belong to distinct clade of
the rhodopsin-β-type G protein-coupled neuropeptide–receptors,
as illustrated in Figure 1A. Not all of the receptors in this clade
are activated by RFamide-type neuropeptides (e.g., tachykinin
receptors and leucokinin receptors). But some of the invertebrate
FIGURE 4 | Summary of RFamide-type peptides and receptors that
have been identified in representative deuterostomian taxa. A gray
triangle in the bottom right indicates that a receptor has been identified but
a candidate ligand has not yet been identified. A gray triangle in the top left
indicates that a peptide(s) has been identified but a candidate cognate
receptor has not yet been identified. An empty white square indicates that
neither a receptor nor a candidate peptide has been identified. The color of
the triangle indicates that the peptide is either a Phe-amide (Fa, green), a
Tyr-amide, or Trp-amide (Y/Wa, orange) or unknown (gray) in a given species
or group of species. The last column of squares to the right describes the
expected situation in the last common ancestral protostomian
(u-protostomia). A supplementary table provides further details of IDs for
the sequence data used to compile this figure.
members of this receptor clade are activated by RFamide-type
peptides (e.g., luqin, NPF), while their vertebrate counterparts
have either been lost or are activated by peptides with C-terminal
motifs that are structurally similar to RFamide (e.g., RYamide in
NPY-type peptides). Therefore, we speculate that the common
ancestor of this clade of receptors may have been activated by
a neuropeptide with a C-terminal RFamide motif. If this is cor-
rect, then we have a scenario where multiple gene duplications
followed by diversification has given rise to neuropeptides where
the C-terminal RFamide motif has either been retained, slightly
modified (e.g., RYamide or RWamide) or lost, but with different
patterns of retention, modification, or loss occurring in different
branches of the animal kingdom.
But the RFamide motif is not unique to neuropeptide ligands
of the clade of rhodopsin-β-type G protein-coupled receptors
that includes GnIH-, NPFF-, QRFP-, and PrRP-type receptors.
As highlighted above, the ligands for CCK/gastrin-type recep-
tors in protostomian invertebrates also have an RFamide motif
(Figures 1A and 3B). This may be a consequence of convergent
evolution, with CCK/gastrin-type neuropeptides having acquired
an RFamide motif in the protostomian lineage. However, an
alternative, and more provocative, hypothesis would be that the
RFamide motif in protostomian CCK/gastrin-type neuropeptides
reflects conservation of an ancient motif that was a characteristic
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of the neuropeptide ligand that activated the receptor that is
the common ancestor of all rhodopsin-β-type G protein-coupled
neuropeptide–receptors in bilaterians.
In this scenario, neuropeptide diversification following multi-
ple gene duplications would have resulted in loss of the RFamide
motif in many of the neuropeptides that act as ligands for
rhodopsin-β-type G protein-coupled neuropeptide–receptors in
bilaterians. Support for the notion of an ancient RFamide neu-
ropeptide signaling system can be found in the discovery that
neuropeptides with an RFamide-type motif are present not only
in bilaterians but also in basal animal groups such as the cnidar-
ians (7, 84). However, the receptors that mediate the effects
of RFamide-type neuropeptides in cnidarians have, as yet, not
been identified and it is possible, of course, that receptors for
RFamides in cnidarians are not rhodopsin-β-type receptors. Fur-
thermore, the RFamide motif does appear to be a convergent
feature of neuropeptide systems and this can be seen in kisspeptins,
which exert effects via rhodopsin-γ-type G protein-coupled recep-
tors. Thus, neuropeptides with a C-terminal RFamide motif
act as ligands for both rhodopsin-β-type G protein-coupled
receptors (GnIH-, NPFF-, QRFP-, and PrRP-type receptors) and
rhodopsin-γ-type G protein-coupled receptors (kisspeptin-type
receptors).
Interestingly, the abundance of neuropeptide types that share a
C-terminal RFamide-type or RFamide-like motif (e.g., RYamide)
could, in principle, give rise to cross-talk between neuropeptide
signaling systems. Thus, a promiscuous RFamide receptor could
potentially bind multiple RFamide-type neuropeptides derived
from a variety of different precursor proteins. However, evi-
dence that this occurs physiologically has, to the best of our
knowledge, not been obtained. Demonstrating it will require evi-
dence of not only peptide-receptor interaction in vitro, but also
in vivo.
In conclusion, the RFamide motif appears to be both an ancient
and a convergent feature of neuropeptide evolution, which then
poses the ultimate question as to why this is. It has been proposed
that from an enzymatic perspective, the occurrence of an arginine
residue in the penultimate position may be a preferred characteris-
tic for cleavage at neighboring monobasic or dibasic cleavage sites.
Furthermore, non-polar and aromatic (e.g., phenylalanine and
tyrosine) amino acids may be favored substrates for C-terminal
amidation (15). Another observation that could explain the occur-
rence of C-terminal aromatic residues (Phe, Tyr, and Trp) in many
neuropeptides, including RFamides, is the fact that rhodopsin
α, a class of receptors phylogenetically related to neuropeptide–
receptors (85) (see also Figure 1A), bind monoamine neurotrans-
mitters (dopamine, norepinephrine, tyramine, and serotonin),
which all have an aromatic functional group that is similar to
the aromatic amino acids. This observation raises the possibility
that ancestral neuropeptide ligands for rhodopsin-type receptors
could have been peptides with a C-terminal aromatic amino acid
(Phe/Tyr/Trp-amides).
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